We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Geron’s Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial

News   Jun 13, 2007

 
Geron’s Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
 
 
 

RELATED ARTICLES

Cultivating 4D Tissues – the First Self-curving Cornea

News

Scientists have developed a biological system which lets cells form a desired shape by moulding their surrounding material - initially creating the world's first self-curving cornea.

READ MORE

Placental Mitochondria Adapt When Mothers Have Poor Diets or Low Oxygen

News

Using mice to model conditions in the womb, Cambridge researchers have provided new insights on how the placenta regulates how much oxygen and nutrients it transports to babies during challenging pregnancies.

READ MORE

Targeting Tiny ‘Pocket' to Treat Stroke and Seizure

News

The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE